CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 3 Multicenter, Randomized, Open Label, Active-controlled, Study of AMG 510 Versus Docetaxel for the Treatment of Previously Treated Locally Advanced and Unresectable or Metastatic NSCLC Subjects With Mutated KRAS p.G12C

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04303780
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-07-23T00:02:39.934712+00:00
Published At: 2023-05-10T00:00:00+00:00
Record Updated At: 2026-07-22
Results Posted At: 2023-05-10
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["KRAS p, G12c Mutated /Advanced Metastatic NSCLC"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-07-22"
protocolSection.identificationModule.nctId: "NCT04303780"
protocolSection.identificationModule.officialTitle: "A Phase 3 Multicenter, Randomized, Open Label, Active-controlled, Study of AMG 510 Versus Docetaxel for the Treatment of Previously Treated Locally Advanced and Unresectable or Metastatic NSCLC Subjects With Mutated KRAS p.G12C"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2023-05-10"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.